Lydia Wu is a health and life sciences analyst at Gates Ventures, where she supports the Diagnostics Accelerator initiative in partnership with the Alzheimer’s Drug Discovery Foundation. Prior to this, Wu was a business analyst at McKinsey & Company, serving life sciences organizations on topics such as optimizing clinical trial strategy and improving R&D productivity. She holds a bachelor of arts in biology from Columbia University.